Neural grafts in Huntington's disease: viability after 10 years

The Lancet Neurology

Volumn 8, Issue 11, 2009, Pages 979-981

  Bachoud Lévi, Anne Catherine ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

APOPTOSIS; AUTOPSY; BRAIN CELL; CELL LOSS; CELL TRANSPLANTATION; FOLLOW UP; HUMAN; HUNTINGTON CHOREA; LETTER; LIFE EXPECTANCY; NERVE GRAFT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; TREATMENT OUTCOME; GRAFT SURVIVAL; NERVE CELL; PATHOLOGY; PHYSIOLOGY; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

APOPTOSIS; AUTOPSY; GRAFT SURVIVAL; HUMANS; HUNTINGTON DISEASE; NEURONS; STEM CELL TRANSPLANTATION;

EID: 70449698433     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70278-9     Document Type: Letter

References (12)

1. Peschanski M., Cesaro P., and Hantraye P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 68 (1995) 273-285
2. Rosser A.E., and Dunnett S.B. Cell transplantation for Huntington's disease should we continue?. Br Res Bull 72 (2007) 132-147
3. Cicchetti F., Saporta S., Hauser R.A., et al. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci USA 106 (2009) 12483-12488
4. Hauser R.A., Furtado S., Cimino C.R., et al. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 58 (2002) 687-695
5. Furtado S., Sossi V., Hauser R.A., et al. Positron emission tomography after fetal transplantation in Huntington's disease. Ann Neurol 58 (2005) 331-337
6. Bachoud-Lévi A.C., Gaura V., Brugières P., et al. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 5 (2006) 303-309
7. Krystkowiak P., Gaura V., Labalette M., et al. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PLoS ONE 2 (2007) e166
8. Freed C.R., Greene P.E., Breeze R.E., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344 (2001) 710-719
9. Olanow C.W., Goetz C.G., Kordower J.H., et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54 (2003) 403-414
10. Li J.-Y., Englund E., Holton J.L., et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 14 (2008) 501-503
11. Mendez I., Viñuela A., Astradsson A., et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med 14 (2008) 507-509
12. Reuter I., Tai Y.F., Pavese N., et al. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J Neurol Neurosurg Psychiatry 79 (2008) 948-951